DrugPatentWatch Database Preview

Details for Patent: 8,227,471

« Back to Dashboard

Which drugs does patent 8,227,471 protect, and when does it expire?

Patent 8,227,471 protects ADDYI and is included in one NDA.

This patent has thirty-nine patent family members in twenty-nine countries.

Summary for Patent: 8,227,471

Title:	Treating sexual desire disorders with flibanserin
Abstract:	The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
Inventor(s):	Borsini; Franco (Bad Waldsee, DE), Evans; Kenneth Robert (Toronto, CA)
Assignee:	Sprout Pharmaceuticals, Inc. (Raleigh, NC)
Application Number:	11/524,268
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 8,227,471

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Sprout Pharms	ADDYI	flibanserin	TABLET;ORAL	022526-001	Aug 18, 2015		RX	Yes	Yes						USE OF FLIBANSERIN OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF TO TREAT HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)

Foreign Priority and PCT Information for Patent: 8,227,471

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	01125020	Oct 20, 2001

Non-Orange Book US Patents Family Members for Patent 8,227,471

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
7,151,103	Method of treating female hypoactive sexual desire disorder with flibanserin
9,782,403	Treating sexual desire disorders with flibanserin
9,468,639	Treating sexual desire disorders with flibanserin

International Family Members for US Patent 8,227,471

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Eurasian Patent Organization	200400481
Eurasian Patent Organization	007274
Ecuador	SP045069
European Patent Office	1446122